Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yihai Chen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Immunology Research|May 17, 2022
A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast CancerXin Zhang, Xingda Zhang, Guozheng Li, et al.
Frontiers in Surgery|July 15, 2022
Toward Exempting from Sentinel Lymph Node Biopsy in T1 Breast Cancer Patients: A Retrospective StudyGuozheng Li, Jiyun Zhao, Xingda Zhang, et al.
Critical Reviews in Oncology/Hematology|October 28, 2023
Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theoryLei Zhang, Jianli Ma, Lei Liu, et al.
Cell Death & Disease|February 1, 2023
LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axisQin Wang, Guozheng Li, Xin Ma, et al.
Frontiers in Pharmacology|January 3, 2022
Riddle of the Sphinx: Emerging Role of Transfer RNAs in Human CancerZhilin Qiu, Qin Wang, Lei Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 4, 2024
NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addictionGuozheng Li, Xin Ma, Shiyao Sui, et al.
Research (Washington, D.C.)|May 14, 2026
Integrated Proteogenomic Characterization Identifies Breast Cancer Immune Subgroups and Subtype-Specific Therapeutic StrategiesGuozheng Li, Yihai Chen, Yong Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 27, 2025
Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast CancerShouping Xu, Keda Yu, Lei Liu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Immunology Research|May 17, 2022
A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast CancerXin Zhang, Xingda Zhang, Guozheng Li, et al.
Frontiers in Surgery|July 15, 2022
Toward Exempting from Sentinel Lymph Node Biopsy in T1 Breast Cancer Patients: A Retrospective StudyGuozheng Li, Jiyun Zhao, Xingda Zhang, et al.
Critical Reviews in Oncology/Hematology|October 28, 2023
Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theoryLei Zhang, Jianli Ma, Lei Liu, et al.
Cell Death & Disease|February 1, 2023
LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axisQin Wang, Guozheng Li, Xin Ma, et al.
Frontiers in Pharmacology|January 3, 2022
Riddle of the Sphinx: Emerging Role of Transfer RNAs in Human CancerZhilin Qiu, Qin Wang, Lei Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 4, 2024
NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addictionGuozheng Li, Xin Ma, Shiyao Sui, et al.
Research (Washington, D.C.)|May 14, 2026
Integrated Proteogenomic Characterization Identifies Breast Cancer Immune Subgroups and Subtype-Specific Therapeutic StrategiesGuozheng Li, Yihai Chen, Yong Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 27, 2025
Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast CancerShouping Xu, Keda Yu, Lei Liu, et al.
Pageof 1